P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)
South Korea · Delayed Price · Currency is KRW 1,914.00
-12.00 (-0.62%)
At close: Jun 4, 2026
P&K Skin Research Center Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 3,816 | 4,685 | 5,816 | 4,813 | 7,130 |
Depreciation & Amortization | 2,071 | 2,054 | 1,848 | 1,735 | 1,468 |
Loss (Gain) From Sale of Assets | -4.53 | -5.58 | 0.31 | 0 | 0.97 |
Loss (Gain) From Sale of Investments | 511.96 | 760.03 | -712.69 | -140.01 | 185.18 |
Stock-Based Compensation | - | - | 15.84 | 65.71 | 65.98 |
Provision & Write-off of Bad Debts | 54.05 | 32.12 | 61.72 | 80.73 | 48.15 |
Other Operating Activities | -274.45 | -179.2 | 682.78 | -1,263 | -439.34 |
Change in Accounts Receivable | -458.87 | -637.28 | 236.27 | 146.84 | -753.86 |
Change in Inventory | - | -59.13 | - | - | - |
Change in Accounts Payable | 16.23 | 65.04 | - | - | - |
Change in Other Net Operating Assets | 41.31 | -34.23 | 1,083 | 110.94 | -198.24 |
Operating Cash Flow | 5,773 | 6,681 | 9,032 | 5,549 | 7,507 |
Operating Cash Flow Growth | -30.38% | -26.03% | 62.77% | -26.08% | - |
Capital Expenditures | -1,223 | -1,504 | -622.12 | -1,526 | -1,230 |
Sale of Property, Plant & Equipment | 8.36 | 8.36 | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | -33.34 | -126.01 |
Investment in Securities | -4,462 | -7,072 | -8,102 | 6,468 | -2,457 |
Other Investing Activities | 317.86 | 239.83 | - | -786.62 | -406.26 |
Investing Cash Flow | -5,559 | -7,728 | -8,874 | 972.22 | -4,320 |
Long-Term Debt Repaid | - | -469.33 | -394.27 | -372.54 | -318.02 |
Net Debt Issued (Repaid) | -483.35 | -469.33 | -394.27 | -372.54 | -318.02 |
Issuance of Common Stock | - | - | - | - | 1,495 |
Repurchase of Common Stock | - | - | -2,386 | -610.61 | - |
Dividends Paid | -976.98 | -976.98 | -714.68 | -872.08 | -892.93 |
Other Financing Activities | - | - | - | 149 | -0 |
Financing Cash Flow | -1,460 | -1,446 | -3,495 | -1,706 | 283.73 |
Foreign Exchange Rate Adjustments | -0 | -0.01 | 0.52 | 0.01 | 0.03 |
Net Cash Flow | -1,246 | -2,493 | -3,336 | 4,815 | 3,471 |
Free Cash Flow | 4,550 | 5,177 | 8,410 | 4,023 | 6,277 |
Free Cash Flow Growth | -36.48% | -38.45% | 109.06% | -35.91% | - |
Free Cash Flow Margin | 20.17% | 22.72% | 47.12% | 27.10% | 34.96% |
Free Cash Flow Per Share | 156.95 | 179.25 | 289.65 | 134.13 | 210.50 |
Cash Interest Paid | 49.68 | 46.22 | 24.34 | 30.48 | 23.93 |
Cash Income Tax Paid | 1,545 | 1,544 | 681.74 | 1,329 | 1,178 |
Levered Free Cash Flow | 2,511 | 3,835 | 3,915 | -2,996 | - |
Unlevered Free Cash Flow | 2,544 | 3,868 | 3,931 | -2,976 | - |
Change in Working Capital | -401.34 | -665.6 | 1,319 | 257.78 | -952.1 |